Blockage of JAK/STAT signalling attenuates renal ischaemia-reperfusion injury in rat

Nephrology Dialysis Transplantation

Volumn 23, Issue 1, 2008, Pages 91-100

  Yang, Niansheng ^a   Luo, Mingqian ^a   Li, Rong ^a   Huang, Yuefang ^a   Zhang, Rui ^a   Wu, Qingqing ^a   Wang, Fang ^a   Li, Youji ^a   Yu, Xueqing ^a  

^a SUN YAT SEN UNIVERSITY   (China)

Author keywords

Inflammation; Ischaemia reperfusion; Kidney; Macrophage

Indexed keywords

CELL ADHESION MOLECULE; CHEMOKINE; INTERCELLULAR ADHESION MOLECULE 1; JANUS KINASE; JANUS KINASE 2; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1; N BENZYL 2 CYANO 3 (3,4 DIHYDROXYPHENYL)ACRYLAMIDE; STAT PROTEIN; STAT1 PROTEIN; STAT3 PROTEIN; JAK2 PROTEIN, RAT; TYRPHOSTIN; TYRPHOSTIN AG-490;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME INHIBITION; HISTOPATHOLOGY; INFLAMMATION; KIDNEY FUNCTION; KIDNEY INJURY; KIDNEY ISCHEMIA; MACROPHAGE; MALE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REPERFUSION INJURY; SIGNAL TRANSDUCTION; ANIMAL; DRUG ANTAGONISM; KIDNEY; SPRAGUE DAWLEY RAT; VASCULARIZATION;

ANIMALS; JANUS KINASE 2; KIDNEY; MALE; RATS; RATS, SPRAGUE-DAWLEY; REPERFUSION INJURY; STAT TRANSCRIPTION FACTORS; TYRPHOSTINS;

EID: 44449175602     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfm509     Document Type: Article

References (46)

1. Thadhani R, Pascual M, Bonventre JV. Acute renal failure. N Engl J Med 1996; 334: 1448-1460
2. Bonventre JV, Weinberg JM. Recent advances in the pathophysiology of ischemic acute renal failure. J Am Soc Nephrol 2003; 14: 2199-2210
3. Bonventre JV, Zuk A. Ischemic acute renal failure: an inflammatory disease? Kidney Int 2004; 66: 480-485
4. Donnahoo KK, Meng X, Ayala A, Cain MP, Harken AH, Meldrum DR. Early kidney TNF-alpha expression mediates neutrophil infiltration and injury after renal ischemia-reperfusion. Am J Physiol 1999; 277: R922-R929
5. Daemen MA, van't Veer C, Wolfs TG, Buurman WA. Ischemia/reperfusion- induced IFN-gamma up-regulation: involvement of IL-12 and IL-18. J Immunol 1999; 162: 5506-5510
6. Furuichi K, Wada T, Yokoyama H, Kobayashi KI. Role of Cytokines and Chemokines in Renal Ischemia-Reperfusion Injury. Drug News Perspect 2002; 15: 477-482
7. Safirstein R, Megyesi J, Saggi SJ et al. Expression of cytokine-like genes JE and KC is increased during renal ischemia. Am J Physiol 1991; 261: F1095-F1101
8. Segerer S, Nelson PJ, Schlondorff D. Chemokines, chemokine receptors, and renal disease: from basic science to pathophysiologic and therapeutic studies. J Am Soc Nephrol 2000; 11: 152-176
9. Kapper S, Beck G, Riedel S et al. Modulation of chemokine production and expression of adhesion molecules in renal tubular epithelial and endothelial cells by catecholamines. Transplantation 2002; 74: 253-260
10. Chiao H, Kohda Y, McLeroy P, Craig L, Housini I, Star RA. Alpha-melanocyte-stimulating hormone protects against renal injury after ischemia in mice and rats. J Clin Invest 1997; 99: 1165-1172
11. Fu XY, Schindler C, Improta T et al. The proteins of ISGF-3, the interferon alpha-induced transcriptional activator, define a gene family involved in signal transduction. Proc Natl Acad Sci USA 1992; 89: 7840-7843
12. Schindler C, Strehlow I. Cytokines and STAT signaling. Adv Pharmacol 2000; 47: 113-174
13. Gadina M, Hilton D, Johnston JA et al. Signaling by type I and II cytokine receptors: ten years after. Curr Opin Immunol 2001; 13: 363-373
14. Darnell JE,Jr, Kerr IM, Stark GR. Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins. Science 1994; 264: 1415-1421
15. Ihle JN. STATs: signal transducers and activators of transcription. Cell 1996; 84: 331-334
16. Mascareno E, El-Shafei M, Maulik N et al. JAK/STAT signaling is associated with cardiac dysfunction during ischemia and reperfusion. Circulation 2001; 104: 325-329
17. Banes AK, Shaw S, Jenkins J et al. Angiotensin II blockade prevents hyperglycemia-induced activation of JAK and STAT proteins in diabetic rat kidney glomeruli. Am J Physiol Renal Physiol 2004; 286: F653-F659
18. De Greef KE, Ysebaert DK, Persy V, Vercauteren SR, De Broe ME. ICAM-1 expression and leukocyte accumulation in inner stripe of outer medulla in early phase of ischemic compared to HgCl2-induced ARF. Kidney Int 2003; 63: 1697-1707
19. Yang N, Isbel NM, Nikolic-Paterson DJ et al. Local macrophage proliferation in human glomerulonephritis. Kidney Int 1998; 54: 143-151
20. Levitzki A, Gazit A. Tyrosine kinase inhibition: an approach to drug development. Science 1995; 267: 1782
21. Meydan N, Grunberger T, Dadi H et al. Inhibition of acute lymphoblastic leukaemia by a Jak-2 inhibitor. Nature 1996; 379: 645-648
22. Leonard MO, Hannan K, Burne MJ et al. 15-Epi-16- (parafluorophenoxy)-lipoxin A(4)-methyl ester, a synthetic analogue of 15-epi-lipoxin A(4), is protective in experimental ischemic acute renal failure. J Am Soc Nephrol 2002; 13: 1657-1662
23. Star RA. Treatment of acuter renal failure. Kidney Int 1998; 54: 1817-1831
24. Yamashita J, Itoh M, Kuro T et al. Pre- or post-ischemic treatment with a novel Na+/Ca2+ exchange inhibitor, KBR7943, shows renal protective effects in rats with ischemic acute renal failure. J Pharmacol Exp Ther 2001; 296: 412-419
25. Kelly KJ, Willians WW, Colvin RB, Bonventre JV. Antibody to intercellular molecule-1 protects the kidney against ischemic injury. Proc Natl Acad Sci 1994; 91: 812-822
26. Nakajima A, Ueda K, Takaoka M et al. Effects of pre- and post-ischemic treatments with FK409, a nitric oxide donor, on ischemia/reperfusion-induced renal injury and endothelin-1 production in rats. Biol Pharm Bull 2006; v29: 577-579
27. Schrier RW. Need to intervene in established acute renal failure. J Am Soc Nephrol 2004; 15: 2756-2758
28. Devarajan P. Update on mechanisms of ischemic acute kidney injury. J Am Soc Nephrol 2006; 17: 1503-1520
29. Rosner D, Stoneman V, Littlewood T et al. Interferon-gamma induces Fas trafficking and sensitization to apoptosis in vascular smooth muscle cells via a PI3K- and Akt-dependent mechanism. Am J Pathol 2006; 168: 2054-2063
30. Arany I, Megyesi JK, Nelkin BD, Safirstein RL. STAT3 attenuates EGFR-mediated ERK activation and cell survival during oxidant stress in mouse proximal tubular cells. Kidney Int 2006; 70: 669-674
31. Friedewald JJ, Rabb H. Inflammatory cells in ischemic acute renal failure. Kidney Int 2004; 66: 486-490
32. Kelly KJ, Willians WW, Colvin RB et al. Intercellular adhesion molecule-1-deficient mice are protected against ischemic renal injury. J Clin Invest 1996; 97: 1056-1063
33. Haller H, Dragun D, Miethke A et al. Antisense oligonucleotides for ICAM-1 attenuate reperfusion injury and renal failure in the rat. Kidney Int 1996; 50: 473-480
34. Chang YJ, Holtzman MJ, Chen CC. Differential role of Janus family kinases (JAKs) in interferon-gamma-induced lung epithelial ICAM-1 expression: involving protein interactions between JAKs, phospholipase Cgamma, c-Src, and STAT1. Mol Pharmacol 2004; 65: 589-598
35. Kim OS, Park EJ, Joe EH, Jou I. JAK-STAT signaling mediates gangliosides-induced inflammatory responses in brain microglial cells. J Biol Chem 2002; 277: 40594-40601
36. Walter MJ, Look DC, Tidwell RM, Roswit WT, Holtzman MJ. Targeted inhibition of interferon-gamma-dependent intercellular adhesion molecule-1 (ICAM-1) expression using dominant-negative Stat1. J Biol Chem 1997; 272: 28582-28589
37. Daha MR, van Kooten C. Is the proximal tubular cell a proinflammatory cell? Nephrol Dial Transplant 2000; 15: 41-43
38. Sung FL, Zhu TY, Au-Yeung KK, Siow YL, O Karmin. Enhanced MCP-1 expression during ischemia/reperfusion injury is mediated by oxidative stress and NF-kappaB. Kidney Int 2002; 62: 1160-1170
39. Day YJ, Huang L, Ye H, Linden J, Okusa MD. Renal ischemia-reperfusion injury and adenosine 2A receptor-mediated tissue protection: Role of macrophages. Am J Physiol Renal Physiol 2005; 288: F722-F731
40. Ip WK, Wong CK, Lam CW. Interleukin (IL)-4 and IL-13 upregulate monocyte chemoattractant protein-1 expression in human bronchial epithelial cells: involvement of p38 mitogen-activated protein kinase, extracellular signal-regulated kinase 1/2 and Janus kinase-2 but not c-Jun NH2-terminal kinase 1/2 signalling pathways. Clin Exp Immunol 2006; 145: 162-172
41. Ozawa A, Tada H, Sugawara Y et al. Endogenous IL-15 sustains recruitment of IL-2Rbeta and common gamma and IL-2-mediated chemokine production in normal and inflamed human gingival fibroblasts. J Immunol 2004; 173: 5180-5188
42. Burysek L, Syrovets T, Simmet T. The serine protease plasmin triggers expression of MCP-1 and CD40 in human primary monocytes via activation of p38 MAPK and janus kinase (JAK)/STAT signaling pathways. J Biol Chem 2002; 277: 33509-33517
43. Bian ZM, Elner VM, Yoshida A, Kunkel SL, Elner SG. Signaling pathways for glycated human serum albumin-induced IL-8 and MCP-1 secretion in human RPE cells. Invest Ophthalmol Vis Sci 2001; 42: 1660-1668
44. Simon AR, Rai U, Fanburg BL, Cochran BH. Activation of the JAK-STAT pathway by reactive oxygen species. Am J Physiol 1998; 275(6 Pt 1):C1640-C1652
45. Nakajima H, Takenaka M, Kaimori JY et al. Activation of the signal transducer and activator of transcription signaling pathway in renal proximal tubular cells by albumin. J Am Soc Nephrol 2004; 15: 276-285
46. Ihle JN. The Stat family in cytokine signaling. Curr Opin Cell Biol 2001; 13: 211-217